The Consolidated Appropriations Act (CAA), 2021, includes a prohibition on gag clauses. As such, it prohibits clauses that prevent cost and quality data disclosures in ANY agreement between an issuer or group health plan with a health care provider, network or association of providers, and a third-party administrator (TPA), or other service provider offering access to a network of providers. (more…)
The IRS announced the new Affordable Care Act (ACA) affordability percentage of 8.39% for 2024 employer health care plans. The amount represents the greatest annual decrease since its inception. (more…)
The IRS released Revenue Procedure 2023-23 to provide the inflation-adjusted limits for health savings accounts (HSAs) and high deductible health plans (HDHPs) for 2024. Read more…
The deadline for health plans and health insurance issuers to submit their second prescription drug data collection (RxDC) report is June 1, 2023. This is an annual reporting requirement; plans and issuers will generally submit these reports by June 1 of each year, reporting information for the prior calendar year. Read more…
The IRS released a set of frequently asked questions (FAQs) to address whether certain costs related to general health, nutrition and wellness are medical expenses that can be paid or reimbursed by a health savings account (HSA), health flexible spending account (FSA) or health reimbursement arrangement (HRA). Read more…
The Departments of Labor, Health and Human Services and the Treasury (Departments) issued FAQs on the prohibition of gag clauses under the transparency provisions of the Consolidated Appropriations Act, 2021 (CAA). These FAQs require health plans and health insurance issuers to submit their first attestation of compliance with the CAA’s prohibition of gag clauses by December 31, 2023. Read more…